| Name | Title | Contact Details |
|---|
Moxie is a revolutionary new animate companion for children designed to help promote social, emotional and cognitive development through play-based learning.
Kindbridge Behavioral Health is a company that provides online mental health services across the USA with a focus on gambling and gaming disorder treatment and therapy.
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world’s most expensive epidemic diseases. We do this by developing cost-effective medical technologies that save and improve lives. St. Jude Medical provides safe and effective technologies that are of the highest quality—and that quality is something we take very seriously because we know patients around the world rely on our technologies. Our approximately 18,000 employees are passionate in their commitment to this priority. Headquartered in St. Paul, Minn., St. Jude Medical has four major clinical focus areas: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation. The St. Jude Medical product portfolio includes implantable cardioverter defibrillators (ICDs), cardiac resynchronization therapy (CRT) devices, pacemakers, remote monitoring systems, cardiac mapping and visualization systems, catheter-based ablation devices, vascular closure devices, structural heart products, spinal cord stimulation, peripheral nerve stimulation and deep brain stimulation devices. All qualified applicants will receive consideration for employment without regard to race, color, creed, religion, sex, national origin, marital status, age, citizenship, protected veteran status, sexual orientation, gender identity and/or gender expression, status with respect to public assistance, or disability status.
HealthLeaders-InterStudy is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Knight Therapeutics Inc., headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. Knight Therapeutics' shares are expected to begin trading on the TSX-V on March 3, 2014 under the symbol GUD.